PAUL BISARO Insider Trading $AGN Allergan plc
Get free email notifications about insider trading for PAUL BISARO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL BISARO. PAUL BISARO is in BARR PHARMACEUTICALS INC ($BRL) and President & COO in BARR PHARMACEUTICALS INC ($BRL) and Director in TherapeuticsMD, Inc. ($TXMD) and President and CEO in IMPAX LABORATORIES INC ($IPXL) and Director in ZIMMER BIOMET HOLDINGS, INC. ($ZBH) and Director in Zoetis Inc. ($ZTS) and Director in Allergan plc ($AGN) and Exec Chairman in Allergan plc ($AGN) and Director in Amneal Pharmaceuticals, Inc. ($AMRX) and Executive Chairman in Amneal Pharmaceuticals, Inc. ($AMRX).
PAUL BISARO in Allergan plc
Trading Symbol: AGNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL BISARO: Director, Exec Chairman
Holdings: 263,729 shares
Current Value: $61,825,989
Latest Transaction: May 04 2018
$AGN Market Capitalization: $87.25B
$AGN Previous Close: $234.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PAUL BISARO in Allergan plc
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGN, AMRX, BRL, IPXL, TXMD, ZBH, ZTS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2018 | AGN | Allergan plc | BISARO PAUL | Director | Grant | A | 151.07 | 1,985 | 299,874 | 263,729 | 261.7 K to 263.7 K (+0.76 %) |
May 03 2018 | AGN | Allergan plc | BISARO PAUL | Director | Payment of Exercise | F | 152.94 | 588 | 89,929 | 261,744 | 262.3 K to 261.7 K (-0.22 %) |
Mar 06 2018 | AGN | Allergan plc | BISARO PAUL | Director | Payment of Exercise | F | 148.73 | 2,921 | 434,440 | 262,332 | 265.3 K to 262.3 K (-1.10 %) |
Jan 02 2018 | AGN | Allergan plc | BISARO PAUL | Director | Payment of Exercise | F | 163.58 | 6,521 | 1,066,705 | 265,253 | 271.8 K to 265.3 K (-2.40 %) |
Oct 30 2017 | AGN | Allergan plc | BISARO PAUL | Director | Option Exercise | M | 0.00 | 37,727 | 0 | 0 | |
Oct 30 2017 | AGN | Allergan plc | BISARO PAUL | Director | Buy | M | 0.00 | 37,727 | 0 | 271,774 | 234 K to 271.8 K (+16.12 %) |
May 05 2017 | AGN | Allergan plc | BISARO PAUL | Director | Grant | A | 245.25 | 1,223 | 299,941 | 234,047 | 232.8 K to 234 K (+0.53 %) |
May 05 2017 | AGN | Allergan plc | BISARO PAUL | Director | Payment of Exercise | F | 243.76 | 214 | 52,165 | 232,824 | 233 K to 232.8 K (-0.09 %) |
Mar 07 2017 | AGN | Allergan plc | BISARO PAUL | Director | Payment of Exercise | F | 245.63 | 2,862 | 702,993 | 233,038 | 235.9 K to 233 K (-1.21 %) |
Mar 06 2017 | AGN | Allergan plc | BISARO PAUL | Director | Sell | S | 248.40 | 2,371 | 588,956 | 235,900 | 238.3 K to 235.9 K (-1.00 %) |
Mar 06 2017 | AGN | Allergan plc | BISARO PAUL | Director | Sell | S | 247.63 | 27,688 | 6,856,379 | 238,271 | 266 K to 238.3 K (-10.41 %) |
Mar 06 2017 | AGN | Allergan plc | BISARO PAUL | Director | Sell | S | 246.64 | 8,267 | 2,038,973 | 265,959 | 274.2 K to 266 K (-3.01 %) |
Mar 06 2017 | AGN | Allergan plc | BISARO PAUL | Director | Sell | S | 245.73 | 31,674 | 7,783,252 | 274,226 | 305.9 K to 274.2 K (-10.35 %) |
Feb 06 2017 | AGN | Allergan plc | BISARO PAUL | Director | Grant | A | 229.52 | 444 | 101,907 | 305,900 | 305.5 K to 305.9 K (+0.15 %) |
Feb 03 2017 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Option Exercise | C | 229.32 | 7,105 | 1,629,319 | 0 | |
Feb 03 2017 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Payment of Exercise | F | 229.32 | 3,411 | 782,211 | 185,456 | 188.9 K to 185.5 K (-1.81 %) |
Feb 03 2017 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Grant | A | 229.32 | 7,105 | 1,629,319 | 188,867 | 181.8 K to 188.9 K (+3.91 %) |
Dec 30 2015 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Gift | G | 0.00 | 120,000 | 0 | 120,000 | 240 K to 120 K (-50.00 %) |
Aug 24 2015 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Buy | P | 297.42 | 1,000 | 297,422 | 421,755 | 420.8 K to 421.8 K (+0.24 %) |
Mar 09 2015 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Payment of Exercise | F | 295.70 | 1,776 | 525,163 | 420,755 | 422.5 K to 420.8 K (-0.42 %) |
Mar 09 2015 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Grant | A | 0.00 | 13,702 | 0 | 422,531 | 408.8 K to 422.5 K (+3.35 %) |
Mar 09 2015 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Payment of Exercise | F | 295.70 | 1,316 | 389,141 | 408,829 | 410.1 K to 408.8 K (-0.32 %) |
Page: 1